The Scientist

» NIH and disease/medicine

Most Recent

image: Exploring the Epigenetics of Ethnicity

Exploring the Epigenetics of Ethnicity

By | January 11, 2017

Researchers attempt to estimate how much of the human genome’s methylation patterns can be attributed to genetic ancestry.

0 Comments

The US House of Representatives “Select Investigative Panel” recommends that the NIH investigate fetal tissue research, and consider no longer funding certain types. 

1 Comment

image: Do Preprints Belong in Grant Applications?

Do Preprints Belong in Grant Applications?

By | January 6, 2017

As the NIH questions the place of preprints in grant applications, the U.K.’s MRC encourages scientists to submit non-peer–reviewed works for consideration.

2 Comments

image: NIH: Allergen-Exposure Strategy Can Prevent Peanut Allergy

NIH: Allergen-Exposure Strategy Can Prevent Peanut Allergy

By | January 5, 2017

In light of recent allergen-exposure studies, an agency-sponsored panel has formally recommended early introduction of peanuts in an effort to prevent potentially life-threatening allergies.

0 Comments

image: Contributors

Contributors

By | January 1, 2017

Meet some of the people featured in the January 2017 issue of The Scientist.

0 Comments

image: Pharma Redo

Pharma Redo

By | January 1, 2017

Steve Braun of Cures Within Reach, a nonprofit focused on breathing new life into old medicines, describes the potential benefits of drug repurposing.

1 Comment

Oncologists have raised concerns about a mouse study that suggests the vaccine for human papillomavirus could cause brain damage.

0 Comments

image: US Postdocs Grapple with Salary Changes

US Postdocs Grapple with Salary Changes

By | December 16, 2016

Postdocs nationwide were set to have an increased minimum salary or become eligible for overtime pay until a court injunction halted new Department of Labor regulations.

1 Comment

image: Biomedical Research Bill Approved in House

Biomedical Research Bill Approved in House

By | December 1, 2016

The 21st Century Cures Act could provide funds to federal research agencies for the decade and accelerate the drug approval process.

1 Comment

image: Oligonucleotide Therapeutics Near Approval

Oligonucleotide Therapeutics Near Approval

By | December 1, 2016

Successful late-stage clinical trials could mark the maturation of a new drug development platform, but the path to commercialization is not without hurdles.

0 Comments

Popular Now

  1. An Aging-Related Effect on the Circadian Clock
  2. Marching for Science, from Berlin to Sydney
  3. ADHD Linked to Structural Differences in the Brain
  4. Opinion: Is a Clone Really Born at Age Zero?
Business Birmingham